LGP
Pharmaceuticals, Biotechnology & Life Sciences
Little Green Pharma
- Short interest
- 0.00%
- 0.00 pp 30d
- as of 10 Feb 2025
- Reported shorts
- 961
- Shares on issue
- 302.873M
Little Green Pharma (LGP) financials
Results, ratios and statements
Latest result
Year to 31 Mar 2026 (FY26) vs FY25, figures in AUD, the reporting currency
- Revenue
- $42.4Mvs $36.8M (FY25)
- Yahoo Finance, as at 14 Oct 2026
- NPAT
- −$1.4Mvs $3.3M (FY25)
- Yahoo Finance, as at 14 Oct 2026
- EPS (diluted)
- −$0.005vs $0.011 (FY25)
- Yahoo Finance, as at 14 Oct 2026
- Rev YoY
- +15.2%FY
- EPS YoY
- n/mTTM
Key ratios
Year to 31 Mar 2026 (FY); balance sheet at 31 Mar 2026; prices to 14 Oct 2026
- Gross margin
- 71.1%
- Operating margin
- 5.0%
- Net margin
- −3.3%
- FCF margin
- −2.3%
- ROE
- −1.7%
- ROA
- −1.5%
- FCF conversion
- n/a
- Net debt (excl. leases)
- $1.9M
- Net debt / EBITDA
- 0.3×
- Current ratio
- 3.5×
- Interest cover
- 4.7×
- Cash dividends paid / net profit
- n/a
- Market cap
- $19.3M
- P/E
- n/a
- P/B
- 0.2×
Ratios use the reporting currency (AUD); market cap is in AUD. Source: Yahoo Finance, as at 14 Oct 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | FY26 | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Revenue | $42.4M | $36.8M | $25.6M | $19.6M |
| Gross profit | $30.1M | $25.3M | $13.1M | $12.0M |
| Operating income | $2.1M | −$3.5M | −$12.2M | −$13.5M |
| EBITDA | $2.7M | −$742.0K | −$4.5M | −$4.6M |
| EBIT | −$1.1M | −$4.5M | −$7.6M | −$7.6M |
| Interest expense | $455.0K | $326.0K | $602.4K | $928.8K |
| Pretax income | −$1.5M | −$4.8M | −$8.2M | −$8.6M |
| Tax | −$136.0K | −$8.1M | $0 | $0 |
| NPAT | −$1.4M | $3.3M | −$8.2M | −$9.2M |
| Net interest income | −$487.0K | −$367.0K | −$464.4K | −$887.5K |
| EPS basic | −$0.005 | $0.011 | −$0.027 | −$0.037 |
| EPS diluted | −$0.005 | $0.011 | −$0.027 | −$0.037 |
| Shares | 305.9M | 303.3M | 300.1M | 297.9M |
Financial reports
The company's own filings, newest first
- Quarterly Activities Report and Appendix 4CQuarterly Report31 Jul 2026via asx_announcements
- Appendix 4E and 2026 Annual ReportAnnual Results21 May 2026via asx_announcements
- Investor Presentation - March 2026 Quarterly and Appendix 4CQuarterly Report12 May 2026via asx_announcements
- Quarterly Activities Report and Appendix 4CQuarterly Report30 Apr 2026via asx_announcements
- Quarterly Activities Report and Appendix 4CQuarterly Report30 Jan 2026via asx_announcements
- Half Yearly Report and AccountsHalf Year Results21 Nov 2025via asx_announcements
- September 2025 Quarterly & Appendix 4C Investor PresentationQuarterly Report12 Nov 2025via asx_announcements
- Quarterly Activities Report and Appendix 4CQuarterly Report30 Oct 2025via asx_announcements
- Quarterly Activities Report and Appendix 4CQuarterly Report17 Jul 2025via asx_announcements
- FY2025 Annual Report PresentationAnnual Report11 Jun 2025via asx_announcements
Showing 10 of 22 reports